May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Tumor Location Affects the Incidence of Cataract and Retinopathy After Ophthalmic Radiation Therapy: An Analysis of 384 Consecutive Cases
Author Affiliations & Notes
  • N. S. Patel
    The New York Eye Cancer Center, New York, New York
    The New York Eye and Ear Infirmary, New York, New York
  • K. J. Chin
    The New York Eye Cancer Center, New York, New York
  • G. Duvall
    Theragenics Corporation, Buford, Georgia
  • P. T. Finger
    The New York Eye Cancer Center, New York, New York
    The New York Eye and Ear Infirmary, New York, New York
  • Footnotes
    Commercial Relationships  N.S. Patel, None; K.J. Chin, None; G. Duvall, Employee of company, E; P.T. Finger, None.
  • Footnotes
    Support  The EyeCare Foundation, Inc., New York, NY, and Theragenics Corporation, Buford, GA, U.S.A.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 45. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. S. Patel, K. J. Chin, G. Duvall, P. T. Finger; Tumor Location Affects the Incidence of Cataract and Retinopathy After Ophthalmic Radiation Therapy: An Analysis of 384 Consecutive Cases. Invest. Ophthalmol. Vis. Sci. 2008;49(13):45. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To examine how tumor location affects ocular morbidity after ophthalmic plaque radiotherapy with Pd-103 for uveal melanoma.

 
Methods:
 

384 eyes were irradiated and followed for a mean 47.2 months. There were 122 uveal melanomas anterior to the equator and 233 melanomas posterior to the equator. 29 eyes were excluded from the study due to location at the equator. Anterior and posterior tumors had similar largest basal dimensions and subsequent mean plaque size (at 16 and 15.5 mm, respectively) as well as similar AJCC-UICC tumor staging. The mean apical dose for all tumors was 71.2 Gy. The mean lens dose was 25.71 Gy for anterior tumors and 7.31 Gy, for posterior tumors.

 
Results:
 

Only 18 (15%) of the patients plaqued for an anterior uveal melanoma developed secondary retinopathy. In contrast, 130 (56%) of the posterior choroidal melanoma patients developed retinopathy (p value <0.001). The odds ratio for retinopathy was 0.137 if the tumor was located anteriorly. Cataract developed in 43 (39%) phakic eyes with anterior tumors compared with 32 (15%) eyes with posterior tumors (p value <0.001). Patients with a history of cataract extraction (n=34) prior to radiation therapy were eliminated from the cataract analysis. The odds ratio for a cataract was 3.666 if the tumor was located anteriorly.

 
Conclusions:
 

While plaque radiation of anterior melanomas is more likely to cause reversible vision loss secondary to cataract, treatment of posterior tumors is more likely to be associated with radiation retinopathy, maculopathy and irreversible loss of vision.  

 
Keywords: radiation therapy • tumors • uvea 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×